RXO Zukünftiges Wachstum
Future Kriterienprüfungen 3/6
RXO wird ein jährliches Gewinn- und Umsatzwachstum von 99.8% bzw. 4.6% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 102.4% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 7% betragen.
Wichtige Informationen
99.8%
Wachstumsrate der Gewinne
102.38%
EPS-Wachstumsrate
| Transportation Gewinnwachstum | 12.5% |
| Wachstumsrate der Einnahmen | 4.6% |
| Zukünftige Eigenkapitalrendite | 7.04% |
| Analystenabdeckung | Good |
| Zuletzt aktualisiert | 22 Apr 2026 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
RXO: Freight Turn Will Expose Growing Credit Strain And Execution Risk
Analysts have modestly adjusted RXO's target higher by $2 to $17, reflecting updated views on improving truckload spot rates, tighter regulatory enforcement, and early signs of stronger freight demand later this year. Analyst Commentary Across recent research updates, price target moves on RXO have been mixed, with some firms lifting targets while others have trimmed them by $1 to $2.
RXO: Mixed Truckload Recovery And Credit Concerns Will Shape EPS Normalization
RXO's updated analyst price target edges slightly lower, reflecting a modest reduction of fair value to about $15.85 as analysts weigh mixed recent target revisions alongside evolving views on revenue growth, margins and future P/E assumptions. Analyst Commentary Recent Street research around RXO reflects a mix of optimism and caution, with several firms adjusting price targets in both directions as they reassess the trucking and logistics setup, regulatory trends and valuation multiples.RXO: Supply Side Recovery Will Expose Credit Strain And Execution Risk
RXO's analyst price targets have seen mixed adjustments, with some firms trimming and others lifting their views by $1 to $2, as analysts weigh tighter trucking capacity, higher spot rates, and early signs of a potential truckload recovery against nearer term seasonal and regulatory uncertainties. Analyst Commentary Recent research on RXO shows a split view, with some firms lifting targets modestly and others trimming them by $1 to $2.RXO: Supply Side Recovery And Credit Strain Will Limit Future Upside
Analysts have raised their RXO price targets to a range of roughly $11 to $17, citing tighter truckload capacity, improving spot rates, and early indications that contract renewals and regulatory enforcement could support a healthier freight environment over the next couple of years. Analyst Commentary Street research on RXO has shifted into a fairly tight band of expectations, with price targets clustering in the low to mid teens.RXO: Credit Strain And 2026 Capacity Uncertainty Will Limit Upside Potential
The analyst fair value estimate for RXO has moved from $11.00 to $12.00, as analysts weigh a mixed set of price target changes alongside updated assumptions for the discount rate, revenue growth, profit margin, and future P/E multiples. Analyst Commentary Street research on RXO reflects a split view, with several firms lifting price targets while others trim expectations and flag execution and growth risks.RXO, Inc. (NYSE:RXO) Just Released Its Yearly Earnings: Here's What Analysts Think
Feb 12
RXO: AI Execution And Capacity Tightness Will Shape Balanced EPS Normalization Prospects
RXO Narrative Update The updated analyst price target for RXO edges up from about US$15.50 to roughly US$15.89. Analysts factor in modestly higher revenue growth and profit margin assumptions, along with a lower future P/E multiple, informed by recent mixed target revisions across major firms.RXO Margin Squeeze Signals A Recovery In Trucking, But The Name Is Still Overpriced
Feb 06RXO, Inc.'s (NYSE:RXO) Price Is Right But Growth Is Lacking After Shares Rocket 29%
Feb 05RXO: AI And Tightening Capacity Will Shape Balanced EPS Recovery Outlook
Narrative Update Analysts have trimmed their blended price target on RXO slightly, with the model fair value moving from about US$15.65 to US$15.50. This reflects mixed Q3 results, revised 2026 earnings assumptions, and differing views on how tightening truckload capacity could support the business over time.RXO: AI Execution Concerns Will Restrain Benefit From 2026 Capacity Tightening
Analysts have nudged their blended price expectations for RXO higher, with our fair value estimate moving from US$10.47 to US$11.00. Recent target changes reflect cautious optimism around capacity tightening, potential truckload recovery into 2026, and the company’s AI execution, tempered by softer recent results and guidance.RXO: AI Execution Will Drive EPS Recovery Despite Short Seller Pressure
Analysts have nudged their average price target on RXO slightly higher to approximately $15.65 from about $15.59, citing expectations that the company can leverage its emerging AI capabilities and cost discipline to support at least $1 of normalized EPS over time, despite near term margin pressure and reduced earnings forecasts. Analyst Commentary Street research on RXO reflects a wide range of views, with bullish analysts emphasizing the company’s AI roadmap and earnings power over the cycle, while bearish analysts focus on weaker recent results and compressed profitability in the current freight backdrop.RXO: AI Brokerage Execution Will Shape Earnings Recovery Amid Heightened Short Seller Scrutiny
The Street narrative on RXO has shifted mildly as analysts trim near term earnings expectations and price targets, while the blended analyst fair value estimate remains effectively unchanged at about $15.59. This comes despite a mix of cuts to the low teens and select upward revisions into the low $20s, reflecting confidence in the company’s AI enabled brokerage strategy.RXO: Artificial Intelligence Deployment Will Drive Industry Leadership and Earnings Recovery
Analysts have slightly reduced their price target for RXO, lowering it by $0.08 to $15.59. They cite ongoing margin pressures and cautious financial outlooks following recent quarterly results.RXO, Inc. (NYSE:RXO) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough
Nov 12RXO: Freight Market Stabilization Will Drive Improving Operational Performance Ahead
Analysts have lowered their price target for RXO from $16.78 to $15.67 per share. They cite disappointing quarterly results, weaker forward guidance, and ongoing headwinds in the freight and logistics market as key drivers of the downward revision.Freight Market Stabilization Will Lead To Opportunities Amid Evolving E-Commerce Trends
Analysts have modestly increased their price target for RXO, citing improved revenue growth projections and stabilizing market conditions. Updated targets now range up by $2 to $22.Digital Freight Matching And E-Commerce Trends Will Reshape Logistics
Analysts have raised their price target for RXO to $17 from $15. This change reflects expectations of a slightly higher fair value, even though there is a more cautious outlook on revenue growth and margins.We Think RXO (NYSE:RXO) Is Taking Some Risk With Its Debt
Jun 24Digital Brokerage Platform Will Unlock Network Effects
Tech-enabled integration and digital platform expansion are improving productivity, margins, and earnings growth while unlocking operating synergies and network effects.A Piece Of The Puzzle Missing From RXO, Inc.'s (NYSE:RXO) 27% Share Price Climb
May 20Not Many Are Piling Into RXO, Inc. (NYSE:RXO) Stock Yet As It Plummets 29%
Apr 05Are Investors Undervaluing RXO, Inc. (NYSE:RXO) By 36%?
Feb 24RXO: The Bear Case Is In Focus (Rating Downgrade)
Feb 09Ryder System: The Ride That Keeps On Delivering
Jan 09Investors Aren't Entirely Convinced By RXO, Inc.'s (NYSE:RXO) Revenues
Dec 23Does RXO (NYSE:RXO) Have A Healthy Balance Sheet?
Nov 10RXO Emerges Stronger With The Freight Recession In The Rearview
Oct 12Here's What's Concerning About RXO's (NYSE:RXO) Returns On Capital
Jun 05RXO, Inc.: Upgrade To Buy On Positive Volume And Pricing Outlook
May 21Insufficient Growth At RXO, Inc. (NYSE:RXO) Hampers Share Price
Apr 10Here's Why RXO (NYSE:RXO) Has A Meaningful Debt Burden
Feb 08Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 12/31/2028 | 6,659 | 69 | N/A | N/A | 5 |
| 12/31/2027 | 6,214 | 30 | 79 | 139 | 18 |
| 12/31/2026 | 5,805 | -45 | 24 | 66 | 18 |
| 12/31/2025 | 5,742 | -100 | -8 | 51 | N/A |
| 9/30/2025 | 5,940 | -79 | -18 | 37 | N/A |
| 6/30/2025 | 5,559 | -308 | -45 | 7 | N/A |
| 3/31/2025 | 5,070 | -306 | -70 | -21 | N/A |
| 12/31/2024 | 4,550 | -290 | -57 | -12 | N/A |
| 9/30/2024 | 3,861 | -263 | -37 | 14 | N/A |
| 6/30/2024 | 3,797 | -21 | -33 | 25 | N/A |
| 3/31/2024 | 3,830 | -11 | -9 | 54 | N/A |
| 12/31/2023 | 3,927 | 4 | 25 | 89 | N/A |
| 9/30/2023 | 4,069 | -2 | 82 | 146 | N/A |
| 6/30/2023 | 4,231 | 12 | 138 | 199 | N/A |
| 3/31/2023 | 4,494 | 53 | 192 | 249 | N/A |
| 12/31/2022 | 4,796 | 92 | 253 | 310 | N/A |
| 9/30/2022 | 5,003 | 138 | 222 | 270 | N/A |
| 6/30/2022 | 5,063 | 158 | 192 | 236 | N/A |
| 3/31/2022 | 4,936 | 149 | 204 | 246 | N/A |
| 12/31/2021 | 4,689 | 150 | 116 | 155 | N/A |
| 12/31/2020 | 3,357 | 43 | -22 | 25 | N/A |
| 12/31/2019 | 3,141 | 62 | 67 | 123 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: RXO wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als schnelleres Wachstum als die Sparquote angesehen wird (3.5%).
Ertrag vs. Markt: RXO wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als überdurchschnittliches Marktwachstum angesehen wird.
Hohe Wachstumserträge: RXO wird voraussichtlich in den nächsten 3 Jahren rentabel werden.
Einnahmen vs. Markt: RXODie Einnahmen des Unternehmens (4.6% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (11.3% pro Jahr).
Hohe Wachstumseinnahmen: RXODie Einnahmen des Unternehmens (4.6% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: RXODie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (7%).
Wachstumsunternehmen entdecken
Unternehmensanalyse und Finanzdaten Status
| Daten | Zuletzt aktualisiert (UTC-Zeit) |
|---|---|
| Unternehmensanalyse | 2026/05/06 02:36 |
| Aktienkurs zum Tagesende | 2026/05/06 00:00 |
| Gewinne | 2025/12/31 |
| Jährliche Einnahmen | 2025/12/31 |
Datenquellen
Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.
| Paket | Daten | Zeitrahmen | Beispiel US-Quelle * |
|---|---|---|---|
| Finanzdaten des Unternehmens | 10 Jahre |
| |
| Konsensschätzungen der Analysten | +3 Jahre |
|
|
| Marktpreise | 30 Jahre |
| |
| Eigentümerschaft | 10 Jahre |
| |
| Verwaltung | 10 Jahre |
| |
| Wichtige Entwicklungen | 10 Jahre |
|
* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.
Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.
Analysemodell und Schneeflocke
Einzelheiten zu dem Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite. Außerdem bieten wir Leitfäden zur Verwendung unserer Berichte und Tutorials auf YouTube an.
Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.
Metriken für Industrie und Sektor
Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.
Analysten-Quellen
RXO, Inc. wird von 24 Analysten beobachtet. 18 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.
| Analyst | Einrichtung |
|---|---|
| Brandon Oglenski | Barclays |
| Brandon Oglenski | Barclays |
| Christopher Kuhn | Benchmark Company |